Latest evidence on COVID-19
General background of SARS-CoV-2, virus evolution, seasonality and survival in the environment.
Incubation period, co-infections and secondary infection, risk factors,risk groups and demographic profiles.
Viral shedding, virus and substances of human origin (SoHO), role of asymptomatic and pre-symptomatic individuals and transmission risks in different settings
Pathology and pathogenesis, symptoms and signs, severity, complications of COVID-19 infection
Diagnostic testing and screening
Diagnostic specimens, assay types, in-house tests versus in vitro diagnostic medical devices, intended use, rapidity and point of testing, diagnostic accuracy and validation, biosafety, testing capacity and methodologies
Immune responses and immunity
Immune responses (cell-mediated immune response and antibody-mediated immune response and protective immunity) and population immunity
Latest risk assessment
Rapid Risk Assessment: Resurgence of reported cases of COVID 19 in the EU/EEA, the UK and EU candidate and potential candidate countries
While decreasing trends in disease incidence are being observed in Europe overall (12% decrease in 14-day incidence of reported cases between 16 and 30 June), there is still community transmission reported in most EU/EEA countries, the UK and EU candidate and potential candidate countries. Additionally, some countries are reporting a resurgence of observed cases or large localised outbreaks.
Coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in December 2019 in Wuhan, China, and has since spread rapidly, evolving into a full-blown pandemic.Read more
Risk assessment on COVID-19, 11 June 2020
ECDC risk assessments aim at supporting the EU/EEA countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for responseRead more